Introduction
T h e endocytic pathway plays an important role in regulating the activities of signalling receptors. Experiments that block the clathrin-mediated internalization of epidermal growth factor receptors have shown that the relative strengths of various signalling pathways associated with the activated receptor are significantly altered as a consequence [l] . Recycling through the early endosome and exposure to the acidic lumen can be used for re-activation of desensitized G-proteincoupled receptors [2] , while sorting to later endosoma1 compartments can target receptors for degradation. One might therefore expect a dialectical relationship between receptor-mediated signal transduction and receptor trafficking. Joly et al. [3] have shown that platelet-derived growth factor receptor down-regulation is inhibited by the phosphoinositide 3-kinase (PI 3-kinase) inhibitor wortmannin and by mutation of the site for recruitment of the p85/p110 PI 3-kinase complex. This is not due to a block of initial uptake, but rather to a block in the transfer of the receptor from the sorting endosome to lysosomally directed elements [4] . With this in mind, we set out to explore the requirement for PI 3-kinase activity of several aspects of endosomal dynamics using the inhibitors wortmannin and LY294002.
Endosome fusion
Early endosomes or sorting endosomes undergo constant remodelling from a plethora of vesicle fusion, fission and vesicle budding events [ 5 ] . We measure the so-called homotypic fusion of early endosomes in a cell-free assay. Fusion is defined as homotypic because fusion partners are operationally defined by identical protocols of internal- ization of a fluid-phase marker prior to cell homogenization. Following incubation of membrane fractions with cytosol plus the requisite salts and ATP-regenerating system, complex-formation of the two internalized markers, which can only result from membrane fusion, is recorded. This fusion event is known to require the ubiquitous fusion factors NSF (soluble N-ethylmaleimide-sensitive factor) and a-SNAP (soluble N S F attachment protein) [6, 7] , as well as an endosomespecific fusion factor, the small GTPase Rab5 [8] .
Our earliest results showed a dose-dependent inhibition of endosome fusion by wortmannin or LY294002 at concentrations entirely consistent with inhibition of a PI 3-kinase enzyme (I(& for wortmannin % 15 nM) [9] . Li et al. [lo] published similar results, together with a further interesting observation. They observed that when a constitutively active mutant of RabS (Q79L, which is defective in GTP hydrolysis) was included in the assay, it was rendered insensitive to wortmannin [ 101. T h e simplest explanation for this result would be that PI 3-kinase activity is required upstream of RabS activation on the fusion pathway. Initially we were unable to reconcile their data with our own results, which showed that under the particular configuration of our assay, which can proceed following pre-incubation with guanosine 5'-[y-thioltriphosphate, thereby locking endogenous Rab5 into the active state, the assay remained sensitive to wortmannin [ l l ] . Titration of the levels of the Rab5 Q79L mutant in the assay provided an explanation. We found that we could render endosome fusion refractory to wortmannin inhibition if we included the mutant at levels far in excess of endogenous levels, i.e. in excess of the amount of Rab5 that could possibly have been inactivated in the first instance. We proposed that PtdIns3Ps were required at the same step of the fusion pathway as Rab5, perhaps to recruit a further fusion factor, and that excess Rab5 could overcome the requirement for these phosphatidylinositols by a mass-action effect [ll] . One should note that this interpretation does not rule out a role for PtdIns3Ps in Rab5 activation as originally proposed and for which further evidence has been put forward [12] , but highlights a late requirement for PtdIns3Ps beyond endogenous RabS activation.
Involvement of early endosomal
antigen I (EEAI) in endosome fusion Patki et al. [13] conducted a search for proteins that are redistributed to the cytosol from membrane fractions in response to wortmannin. They identified a protein with these properties as EEAl, a well defined early-endosome marker [ 141. EEAl is predicted to form an extended coiled-coil structure over most of its length, flanked by two zincfinger domains. T h e C-terminal domain belongs to the FYVE class of zinc fingers (named from the first letters of four proteins containing it), which has now been shown to represent a specific binding domain for PtdIns3P [15-171. We tested the requirement of early endosome fusion for EEAl [18] . We first confirmed that EEAl dissociates from early endosomes of BHK cells following wortmannin treatment, and then explored the possibility that this redistribution can account for the wortmannin sensitivity of endosome fusion. Three lines of evidence have highlighted the involvement of EEAl in an in vitro assay of homotypic endosome fusion [18] : (i) polyclonal antibodies raised against the C-terminal domain of EEAl inhibit endosome fusion; (ii) incorporation of the C-terminal domain of EEAl into the fusion assay displaces endogenous EEAl from membranes and inhibits endosome fusion with a similar dose-dependence; and (iii) depletion of EEAl from the system (by salt treatment of membranes and/or immunoabsorption of cytosol) results in a dimunition of fusion.
T h e requirement of endosome fusion for EEAl, which associates with endosomes in a PI 3-kinase-dependent manner, is sufficient to account for the inhibition of fusion by wortmannin. PtdIns3Ps are not the sole determinant of EEAl membrane localization. Simonsen et al. [19] , as well as presenting data very similar to those described above, provided evidence that Rab5 cooperates with lipid in binding EEAl to endosomes. Co-operativity between two relatively low-affinity reactions can result in high-affinity binding. This may explain the ability of excess amounts of activated RabS to overcome wortmannin inhibition, i.e. by mass action. On the basis of similarities with Usol, a yeast protein involved in transport from the endoplasmic reticulum to the Golgi, we suggested that the role of EEAl in endosome fusion may be to act as a tethering molecule that mediates the initial attachment between fusion partners, prior to the formation of a trans-complex between cognate SNARE (SNAP receptor) molecules [S] . This has recently been shown to be the case using an assay that separates endosome attachment from endosome fusion [20, 21] .
FYVE proteins
The identification of the FYVE domain as a PtdIns3P binding motif was a major advance [13, [15] [16] [17] . There are five proteins with this domain in budding yeast, of which three (Vacl, Vps27 and Fabl) have been implicated in the regulation of membrane traffic. Vaclp is involved in the fusion of Golgi-derived vesicles with endosomes, and binds both PtdIns3P and the RabS homologue Vps2lp [22] . On this basis it is proposed that Vaclp fulfils the function of EEAl in this system. Vaclp also binds to the t-SNARE Pepl2p, and to Vps45p [22] , a protein related to the n-Secl family of proteins that have been proposed to be negative regulators of SNARE-complex assembly through a tubular SNARE (t-SNARE) interaction [23, 24] . This suggests an additional function for Vaclp beyond initial attachment of the vesicle, perhaps regulation of the availability of Pep1 2p for participation in SNARE-complex assembly. Vps27, a class E Vps mutant, has been implicated in transport between endosomes and the vacuole [25] , while Fabl is a PtdIns3P 5-kinase that may regulate the formation of intraluminal vesicles in multivesicular bodies (MVBs) of the endocytic pathway (see below) [26, 27] .
One important issue is whether the endosomal pathway represents the sole site of membrane localization of FYVE-domain-containing proteins, perhaps because it is the major site of PtdIns3P generation. co-localization at the resolution level of the light microscope increases with the Hrs-haemagglutinin expression level, concomitant with formation of larger fluorescent structures that remain distinct from the Golgi apparatus. Using a similar strategy we have also found that haemagglutinin-tagged KIAA0371 displays a punctate labelling pattern distinct from that of endogenous EEAl. T h e identity of this compartment is currently under investigation.
PI 3-kinase requirement for MVB formation
Although internalized fluid-phase markers can clearly reach compartments containing late-endosoma1 markers in the presence of wortmannin [32] , the efficiency of this process has not been accurately quantified. We have used an assay that measures the formation of endosomal carrier vesicles (ECVs) or MVBs from early endosomes of BHK cells by their separation on a velocity flotation gradient [33, 34] . Following a pulse-chase protocol, accumulation of fluid-phase marker at a low-density interface, compared with early-endosome labelling at a higher-density interface, is measured as an index of ECV formation [33] . In the presence of wortmannin, the marker can no longer reach the lower-density compartment, indicating a block to ECV/MVB formation, at least as defined by their centrifugation profile (Figure 1) . Our interpretation is supported by recent studies of human melanoma cells which showed that wortmannin inhibits the pinching-off of intraluminal vesicles, which is presumably required for bona fide ECV/MVB formation [35] . T h ' is can explain the wortmannin block of platelet-derived growth factor receptor trafficking to the late endosomes described by Joly et al. [4] , because tyrosine kinase growth factor receptors destined for down-regulation probably require sorting into Phospholipids: Regulators of Membrane Trafic and Signalling these intraluminal vesicles, as exemplified by the epidermal growth factor receptor [36] . Our results also agree with data from studies on budding yeast indicating that the PtdIns3P 5-kinase activity of Fabl is required for MVB formation [27] and that Vps27 is required for endosome-to-vacuole transport [25] . We propose that wortmannin blocks ECV/MVB formation in BHK cells by denying substrate to a mammalian Fabl homologue and/or by influencing Vps27 function.
Concluding remarks
T h e relevant lipid in both aspects of endosome dynamics we have discussed is PtdIns3P, which acts to facilitate binding of EEAl, to serve as a substrate for Fabl and perhaps to influence Vps27 function. How is this lipid generated within cells?
Several PI 3-kinases have now been identified that demonstrate distinct substrate specificities in v i m [37] . However, the hVps34 enzyme is a particularly strong candidate, as it can only use PtdIns as a substrate [38] . Micro-injection of inhibitory antibodies against this enzyme resulted in redistribution of EEAl to the cytosol, whereas antibodies directed against the pl10a catalytic subunit had no effect on this distribution [39] . PtdIns3P is the most abundant 3-phosphoinositide in a resting cell, the levels of which are relatively insensitive to growth factor stimulation [40] . It is perhaps no surprise, then, that such basic aspects of the endocytic pathway are regulated by a constitutively produced lipid.
T o return to our starting point, it may be that specific receptor trafficking can be coupled to receptor signalling by PI 3-kinase activation, but the effects of general PI 3-kinase inhibitors cannot be interpreted in these terms. More specific approaches will have to be adopted, including sitedirected mutagenesis of receptors and specific inactivation of individual PI 3-kinases. 
Introduction
Phosphoinositide 3-kinase (PI 3-kinase) phosphorylates phosphatidylinositol (PtdIns) and its derivatives in the 3'-position of the inositol ring. The resulting products, called 3'-phosphoinositides, serve as regulators of vital cellular functions, including signal transduction, membrane trafficking and the organization of the actin cytoskeleton [l] . Here we will discuss some recent data that provide insight into how one of the 3'-phosphoinositides, PtdIns3P, functions in the regulation of endocytic membrane trafficking.
Role of Rab5 and PI 3-kinase in endosome fusion
Endocytosis, the process by which vesicles pinch off from the plasma membrane and fuse with early endosomes, is crucial for the cellular uptake of macromolecules and for the down-regulation of surface receptors [2] . Like other pathways of intracellular trafficking, endocytosis is tightly regulated by a protein machinery. One of the key players in endocytic membrane trafficking is the small GTPase Rab5. This protein is reversibly attached to the cytosolic side of the plasma membrane, endocytic vesicles and early endosomes, and its overexpression leads to an increased rate of endocytosis [3, 4] . Rab5 has been reported to regulate the formation of clathrin-coated vesicles from the plasma membrane [5] , but its bestdocumented function is the regulation of fusion between endocytic vesicles and early endosomes, as well as the homotypic fusion between early endosomes [6, 7] . The latter processes are stimulated by the 'active', GTP-bound, form of Rab5, Abbreviations used: PI 3-kinase, phosphoinosiiide 3-kinase; GEF, GDP/GTP exchange factor; EEA I, early-endosomal autoantigen I ; MVB, muitivesicular body. 'To whom correspondence should be addressed. and the expression of a GTPase-deficient Rab5 mutant leads to the occurrence of giant early endosomes due to increased fusion [8] . The GTPbound form of Rab5 recruits a cytosolic complex consisting of Rabaptin-5 and Rabex-5, a GDP/ G T P exchange factor (GEF) for Rab5. This complex is crucial for endocytic membrane fusion, as its immunodepletion from the cytosol inhibits endocytic-vesicle-endosome and endosome-endosome fusion [7, 9] . It is still not clear how the Rabaptin-5-Rabex-5 complex participates in the fusion process, but the association of a G E F with a protein binding to Rab5 * G T P suggests a selfamplification mechanism whereby Rabaptin-5-Rabex-5, bound to Rab5-GTP, may convert a neighbouring RabS . G D P into the GTP-bound form [7] . This could lead to a localized patch of active Rab5 in the membrane.
There is a connection between Rab5 and PI 3-kinase: both of these molecules are required for endocytic membrane fusion [6, 10, 11] , and the presence of excess Rab5. G T P counteracts the inhibitory effect of the PI 3-kinase inhibitor wortmannin on endosome fusion [lo] . Initially the latter observation was interpreted as evidence that PI 3-kinase regulates a G E F of RabS. However, there is no evidence that RabS GEFs, such as Rabex-5, are regulated by PI 3-kinase, and the amount of Rab5. G T P required to counteract the wortmannin inhibition is much higher than the amount of endogenous RabS present [ 121. Therefore alternative explanations have to be sought in order to explain the interplay between Rab5 and PI 3-kinase.
Early-endosomal autoantigen I (EEAI), an effector of Rab5 and Ptdlns3P in endocytic membrane fusion
EEAl was originally discovered as an autoantigen in a subset of patients suffering from lupus
